|
|
|
Volumn 26, Issue , 1996, Pages 127-136
|
|
Clinical development plan: indole-3-carbinol.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 INDOLEMETHANOL;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
INDOLE-3-CARBINOL;
ADULT;
ANIMAL;
ARTICLE;
BREAST TUMOR;
DRUG APPROVAL;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
MOUSE;
PHASE 2 CLINICAL TRIAL;
RAT;
SPRAGUE DAWLEY RAT;
ADULT;
ANIMALS;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II;
DRUG APPROVAL;
FEMALE;
HUMANS;
INDOLES;
MALE;
MICE;
NEOPLASMS, EXPERIMENTAL;
RATS;
RATS, SPRAGUE-DAWLEY;
RESEARCH DESIGN;
|
|
EID: 0030320791
PISSN: 07331959
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|